RNA viruses as virotherapy agents

Related Experiment Video

Updated: Sep 27, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Stephen J Russell1

  • 1Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota 55905, USA. sjr@mayo.edu

Cancer Gene Therapy
|January 11, 2003
PubMed

Insights

RNA viruses show promise for oncolytic virotherapy, targeting cancer by exploiting tumor-specific defects in cellular defenses. Engineering these viruses enhances their tumor specificity and therapeutic potential.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • RNA viruses are emerging as potent oncolytic virotherapy agents.
  • Double-stranded RNA formation activates cellular defenses (PKR, interferon).
  • Tumors often have defective PKR and interferon pathways, promoting viral replication.

Purpose of the Study:

  • To summarize the current status of oncolytic virotherapy using RNA viruses.
  • To highlight seven specific RNA viruses under investigation for cancer treatment.

Main Methods:

  • Review of current research on oncolytic RNA viruses.
  • Analysis of viral characteristics and tumor interactions.
  • Discussion of virus engineering for enhanced specificity.

Main Results:

  • Tumor cells are often permissive to RNA virus replication due to immune pathway defects.
  • Natural or adapted tumor specificity is observed in many oncolytic RNA viruses.
  • Virus engineering offers a route for optimizing oncolytic agents.

Conclusions:

  • Oncolytic RNA virotherapy is a rapidly developing field with significant therapeutic potential.
  • Seven distinct RNA viruses are being explored for their oncolytic capabilities.
  • Further refinement through genetic engineering is key to maximizing efficacy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...